Glenmark Pharmaceuticals Ltd. | Mutual Funds
Mutual Funds that own Glenmark Pharmaceuticals Ltd.
HDFC Mid Cap Opportunities Fund
5,258,100
1.86%
0
1.6%
07/31/2018
HSBC GIF - Indian Equity
2,404,667
0.85%
1,594,530
1.27%
10/31/2017
Vanguard Emerging Markets Stock Index Fund
2,346,772
0.83%
-18,200
0.03%
07/31/2018
Templeton Emerging Markets Investment Trust Plc
2,308,709
0.82%
-12,186
0.7%
03/31/2018
Vanguard Total International Stock Index Fund
2,030,289
0.72%
0
0.01%
07/31/2018
FTIF SICAV - Templeton Asian Smaller Companies Fund
2,023,180
0.72%
0
1.14%
06/30/2018
FTIF SICAV - Templeton Emerging Markets Smaller Companies
1,441,913
0.51%
0
1.35%
06/30/2018
iShares MSCI India ETF
1,437,548
0.51%
-3,535
0.25%
09/06/2018
DSP BlackRock Opportunities Fund
1,325,309
0.47%
0
1.48%
07/31/2018
iShares Core MSCI Emerging Markets ETF
1,232,736
0.44%
0
0.02%
09/05/2018
| Address |
Glenmark House, HDO Corporate Bldg
Mumbai Maharashtra 400099
India
|
|
Employees
|
- |
| Website |
http://www.glenmarkpharma.com |
| Updated |
09/14/2018 |
| Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. It operates through the following segments: India, United States, Latin America, Europe, and Rest of the World. The company was founded by Gracias Saldanha on November 18, 1977 and is headquartered in Mumbai, India. |
